filmov
tv
Breakthroughs in GI Cancer Detection: The Role of AI and Data
Показать описание
Breakthroughs in GI Cancer Detection: The Role of AI and Data | TARGET: Cancer Podcast | Ep. 46
Join us as we explore gastrointestinal (GI) knowledge with renowned expert Dr. Michael Byrne. With extensive medical and AI expertise, Michael provides a unique perspective on early cancer diagnosis and the challenges in detecting GI cancers. From colon to stomach and esophageal cancer, discover advancements in screening techniques and the role of AI in improving outcomes. Uncover the potential of AI solutions in revolutionizing GI healthcare and catching cancer early.
- - - -TimeStamps - - - -
00:00 Introduction
03:32 Detecting GI cancers early
12:20 The role of technology in cancer screening
24:31 AI can help doctors digest patient's data points
35:31 AI as augmented intelligence
49:58 Capsule studies
57:27 "AI in Clinical Medicine" guide
- - - -
#cancertreatment
🔴Like, Subscribe, and Share to see more of this type of content!
— ABOUT DR MICHAEL BYRNE —
Dr. Michael Byrne provides senior leadership and clinical expertise to Satisfai Health and is a clinical innovator with over 20 years of experience as a practicing physician. He is the founder of both Satisfai Health and its former ai4gi joint venture. Dr. Byrne holds the positions of Clinical Professor of Medicine in the Division of Gastroenterology at Vancouver General Hospital and UBC, Director of the Interventional Endoscopy Fellowship at VGH, and former Director of Endoscopy at VGH/UBC. His primary clinical interests lie in the field of ERCP, interventional endoscopy, optical biopsy, colon cancer, pancreaticobiliary disease, and IBD.
Prior to his involvement with Satisfai Health, Dr. Byrne worked in the medical device space and biotech industry. His work included colon cancer genetic testing and novel applications of Photodynamic therapy for gastrointestinal disease.
With a strong research background in both basic science and clinical medicine, Dr. Byrne has received hands-on training in molecular science and pharmacology, in addition to conducting extensive clinical research. He has published over 90 peer-reviewed publications and presented over 100 abstracts at National and International Meetings.
Dr. Byrne graduated from Cambridge and Liverpool Universities and obtained an MD by thesis from the University of Cambridge for his research on Helicobacter Pylori and Cyclooxygenase. After gaining experience in the UK and Ireland, he completed an Interventional Endoscopy Fellowship and served as an attending physician at Duke University Medical Center, North Carolina. In 2003, Dr. Byrne transitioned to his current role in Vancouver.
— ABOUT DR SANJAY JUNEJA —
Dr. Sanjay Juneja is a triple board-certified Hematologist & Medical Oncologist serving as Chief of Oncology Service at Baton Rouge General Hospital, a social & news media personality known as the 'TheOncDoc' with over half a million followers, and one of fifteen social media doctors participating in the Healthcare Leaders in Social Media Round Table Series for the White House.
He has been featured by The Washington Post as well as dozens of national podcasts and regional news channels (PBS, CBS, NBC, NPR), and has given keynote speeches and partnered with American Cancer Society, BeTheMatch, Leukemia & Lymphoma Society, Harvard University, Louisiana Department of Health and several others.
— ABOUT xCURES —
The xCures platform is a direct-to-patient and direct-to-physician portal that identifies the most promising treatment options for advanced cancer patients who are not responding to standard of care therapies.
The platform captures data that also helps accelerate the development of promising new cancer drugs, expand the approved uses of existing drugs, and demonstrate value for reimbursement.
TARGET: Cancer Podcast
TuneIn:
Google Podcasts:
Pandora:
Stitcher:
Amazon Music:
Join us as we explore gastrointestinal (GI) knowledge with renowned expert Dr. Michael Byrne. With extensive medical and AI expertise, Michael provides a unique perspective on early cancer diagnosis and the challenges in detecting GI cancers. From colon to stomach and esophageal cancer, discover advancements in screening techniques and the role of AI in improving outcomes. Uncover the potential of AI solutions in revolutionizing GI healthcare and catching cancer early.
- - - -TimeStamps - - - -
00:00 Introduction
03:32 Detecting GI cancers early
12:20 The role of technology in cancer screening
24:31 AI can help doctors digest patient's data points
35:31 AI as augmented intelligence
49:58 Capsule studies
57:27 "AI in Clinical Medicine" guide
- - - -
#cancertreatment
🔴Like, Subscribe, and Share to see more of this type of content!
— ABOUT DR MICHAEL BYRNE —
Dr. Michael Byrne provides senior leadership and clinical expertise to Satisfai Health and is a clinical innovator with over 20 years of experience as a practicing physician. He is the founder of both Satisfai Health and its former ai4gi joint venture. Dr. Byrne holds the positions of Clinical Professor of Medicine in the Division of Gastroenterology at Vancouver General Hospital and UBC, Director of the Interventional Endoscopy Fellowship at VGH, and former Director of Endoscopy at VGH/UBC. His primary clinical interests lie in the field of ERCP, interventional endoscopy, optical biopsy, colon cancer, pancreaticobiliary disease, and IBD.
Prior to his involvement with Satisfai Health, Dr. Byrne worked in the medical device space and biotech industry. His work included colon cancer genetic testing and novel applications of Photodynamic therapy for gastrointestinal disease.
With a strong research background in both basic science and clinical medicine, Dr. Byrne has received hands-on training in molecular science and pharmacology, in addition to conducting extensive clinical research. He has published over 90 peer-reviewed publications and presented over 100 abstracts at National and International Meetings.
Dr. Byrne graduated from Cambridge and Liverpool Universities and obtained an MD by thesis from the University of Cambridge for his research on Helicobacter Pylori and Cyclooxygenase. After gaining experience in the UK and Ireland, he completed an Interventional Endoscopy Fellowship and served as an attending physician at Duke University Medical Center, North Carolina. In 2003, Dr. Byrne transitioned to his current role in Vancouver.
— ABOUT DR SANJAY JUNEJA —
Dr. Sanjay Juneja is a triple board-certified Hematologist & Medical Oncologist serving as Chief of Oncology Service at Baton Rouge General Hospital, a social & news media personality known as the 'TheOncDoc' with over half a million followers, and one of fifteen social media doctors participating in the Healthcare Leaders in Social Media Round Table Series for the White House.
He has been featured by The Washington Post as well as dozens of national podcasts and regional news channels (PBS, CBS, NBC, NPR), and has given keynote speeches and partnered with American Cancer Society, BeTheMatch, Leukemia & Lymphoma Society, Harvard University, Louisiana Department of Health and several others.
— ABOUT xCURES —
The xCures platform is a direct-to-patient and direct-to-physician portal that identifies the most promising treatment options for advanced cancer patients who are not responding to standard of care therapies.
The platform captures data that also helps accelerate the development of promising new cancer drugs, expand the approved uses of existing drugs, and demonstrate value for reimbursement.
TARGET: Cancer Podcast
TuneIn:
Google Podcasts:
Pandora:
Stitcher:
Amazon Music:
0:59:40
Breakthroughs in GI Cancer Detection: The Role of AI and Data
0:00:59
Breakthroughs in GI Cancer Detection: The Role of AI and Data - PROMO clip
0:03:15
AI could revolutionize cancer detection, according to MIT, Mass General research
0:01:01
Research Highlight: Breakthrough in colon cancer therapies
0:03:06
New blood test could be the next big cancer breakthrough
0:58:52
ctDNA and MRD | 2023 Best of GI Cancer Conference
0:01:26
Researchers make discovery that could lead to early detection of pancreatic cancer
0:00:48
Cell-Free DNA Can Improve GI Cancer Detection
0:03:41
Breakthrough for new experimental treatment for colorectal cancer
0:58:31
Stanford Cancer Institute Breakthroughs in Cancer: Luis Diaz, MD
0:30:08
Keynote Lecture: The Microbiome in GI Cancer - How Relevant is it?
0:01:49
New research identifies earliest signs of colon cancer
0:56:47
Innovations & Breakthroughs in Gastrointestinal Cancers Clinical Trials, Treatments & Patien...
1:04:21
Advances in GI Cancer Care: The Concept and Reality of Precision Medicine
0:05:03
Medical Miracle: A breakthrough in Cancer cure | International News | English News | WION
0:31:04
What's new for colorectal cancer treatment?
0:38:42
Colon, Rectal, and Anal Cancer | 2023 Best of GI Cancer Conference
0:24:10
Early Detection Approaches for the Family of GI Cancers – 2020 Stanford Gastric Cancer Summit
0:02:49
Colorectal Cancer Diagnosis, Staging and Treatment
0:00:47
From Stage IV Colon Cancer Diagnosis to Survivorship
0:03:24
'Tumors just vanished': Cancer patients now in remission after drug trial
1:30:00
Checkpoint Inhibition in GI Cancers: Recent Advances and Their Application in Clinical Practice
0:03:59
Cancer Detection’s Blood Whisperer: Scientists Develop Blood Test for Gastric Cancer
0:02:56
Cancer Disappears In All Patients During Immunotherapy Drug Trial
Комментарии